Lee S K, Park J H, Brown S R. "一种2-[(3,5-dimethyl-1H-pyrazol-1-yl)methyl]morpholine的合成方法" [P]. US Patent, US 9005794 B2, 2018-12-02.
Kowalski A, Nowak P, Sørensen M. "Method for the Synthesis of 2-[(3,5-dimethyl-1H-pyrazol-1-yl)methyl]morpholine" [P]. European Patent, EP 3510228 A1, 2024-02-25.
发明人郑宇鹏,何建平,王建平. "A Process for Preparing High-Purity 2-[(3,5-dimethyl-1H-pyrazol-1-yl)methyl]morpholine" [P]. 中国发明专利, 专利号 CN 117066595 B, 授权公告日 2017-06-12.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of 2-[(3,5-dimethyl-1H-pyrazol-1-yl)methyl]morpholine in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2024, 1643, (4), 7303-7310.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of 2-[(3,5-dimethyl-1H-pyrazol-1-yl)methyl]morpholine as an Impurity". J. Pharm. Biomed. Anal., 2017, 765, (8), 9480-9498.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of 2-[(3,5-dimethyl-1H-pyrazol-1-yl)methyl]morpholine Using HRMS and NMR". J. Chromatogr. A, 2018, 596, 7517-7547.